Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 51NIH 15INDUSTRY 14NETWORK 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 12Thoracic 11Breast 10CNS 5Sarcoma 2Gynecologic 2Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Gliosarcoma 2Glioblastoma 2Brain Neoplasms 2Oligodendroglioma 1Glioma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Radiotherapy 35Doxorubicin 30Ifosfamide 29Cyclophosphamide 24Vincristine 23Filgrastim 23Etoposide 20Temozolomide 14Granulocyte Colony-Stimulating Factor 14Dactinomycin 11Cisplatin 11Trabectedin 10Methotrexate 10Gene Expression Profiling 10Radiation 9Imatinib Mesylate 9Surgical Procedures, Operative 8Polymerase Chain Reaction 8Irinotecan 8Specimen Handling 7Paclitaxel 7Chemotherapy, Adjuvant 7Mesna 6Immunohistochemistry 6Gemcitabine 6Carmustine 6Biopsy 6sargramostim 5pegfilgrastim 5etoposide phosphate 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Bevacizumab × Sarcoma × Clear all
NCT01730950 2022-12-29

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Radiation Therapy Oncology Group

Phase 2 Completed
182 enrolled 19 charts
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT01164189 2019-02-28

TAVAREC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
155 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡